Veterinary drug for treatment and health protection of laying hen habitus

Abstract

The invention relates to a veterinary drug for treatment and health protection of laying hen habitus. The component of the veterinary drug comprises traditional Chinese medicine and Western medicine;the traditional Chinese medicine comprises the following components in contents: 50 to 60g of astragalus membranaceus, 10 to 50g of fructus hordei germinatus, 30 to 40g of medicated leaven, 25 to 35gof angelica sinensis, 40 to 50g of angelica dahurica, 50 to 60g of artemisia argyi, and 20 to 40g of pulsatilla chinensis; the Western medicine comprises the following components in contents: 10 to 15g of metronidazole, 15 to 20g of amoxicillin, 20 to 30g of VC, and 10 to 15g of lactic acid TMP; the traditional Chinese medicine comprises the following components in contents: 55g of astragalus membranaceus, 30g of fructus hordei germinatus, 35g of medicated leaven, 30g of angelica sinensis, 45g of angelica dahurica, 55g of artemisia argyi, and 30g of pulsatilla chinensis; and the Western medicine comprises the following components in contents: 12g of metronidazole, 17g of amoxicillin, 25g of VC, and 12g of acid TMP. The veterinary drug has the advantages that the treatment effect is good, recrudescence cannot occur, the laying hen habitus is improved, the production rate is improved, and the egg quality is improved.

Description

technical field [0001] The invention belongs to the technical field of improving the physique of laying hens, and in particular relates to a veterinary medicine for treating and health-care laying hens. Background technique [0002] As we all know, enteropathy of laying hens is a stubborn disease. Because the intestinal tract of laying hens is the shortest in the animal body, the intestinal absorption is not good, which leads to repeated outbreaks of diarrhea, enteritis, enterotoxicity and other diseases in laying hens. Feed absorption rate decreases, which affects the quality of chickens and production performance, and the quality of eggs, etc. Currently, most of the treatment methods are injections or the use of antibiotics, etc. The disadvantages of these treatment methods are that the process is complicated and the treatment effect is not good. Good, easy to relapse; aiming at the deficiencies in the prior art, the present invention has developed a veterinary medicine fo...

AI Technical Summary

Problems solved by technology

[0002] As we all know, enteropathy of laying hens is a stubborn disease. Because the intestinal tract of laying hens is the shortest in the animal body, the intestinal absorption is not good, which leads to repeated outbreaks of diarrhea, enteritis, enterotoxicity and other diseases in laying hens. Feed absorption rate decreases, which affects the quality of chickens and production performance, and the quality of eggs, etc. Currently, most of the treatment methods are injections or the use of antibiotics, etc. The disadvantages of these treatment methods are that the process is complicated and the treatment effect is not good. Good, easy to relapse; aiming at the deficiencies of the prior art, the present invention has developed a veterinary drug for treating and health-care laying hens with good therapeutic effect, no recurrence, improvement of laying hens physique, productivity and egg quality

Images